Root Financial Partners
ARQT icon

Root Financial Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Root Financial Partners’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$846 Buy
+32
New +$837 ﹤0.01% 3023
2026
Q2 		– Sell
-61
Closed -$1.44K – 597
2026
Q1 		$1.44K Buy
61
+60
+6,000% +$1.53K ﹤0.01% 2455
2025
Q4 		$29 Buy
+1
New +$26 ﹤0.01% 2406

Other funds holding ARQT

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Root Financial Partners's ARQT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 32 shares worth $846. The stake represents ﹤0.01% of the portfolio and ranks #3023 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ARQT as recently as Q1 2026.

Root Financial Partners first reported a position in ARQT in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44K in Q1 2026. 144 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Root Financial Partners held 32 shares of Arcutis Biotherapeutics worth $846 as of Q3 2026.
  • Arcutis Biotherapeutics was a new Root Financial Partners position in Q3 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3023 holding.
  • Root Financial Partners first reported a position in Arcutis Biotherapeutics in Q4 2025 and has held it in 3 quarters since.
  • Root Financial Partners's Arcutis Biotherapeutics position peaked at $1.44K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.